Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
Is a |
Product containing pethidine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pethidine |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
Is a |
pethidinhydrochlorid + promethazinhydrochlorid |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Promethazine hydrochloride |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pethidine hydrochloride |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
Is a |
Product containing pethidine and promethazine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
pethidinhydrochlorid 100 mg/2 ml + promethazinhydrochlorid 50 mg/2 ml injektionsvæske |
Is a |
Product containing promethazine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|